articleThe LancetSep 1, 2006Closed access

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,714
total citations
FWCI
94.19
Percentile
100%
References
26
Citations per year

Authors

13

Topics & keywords

Keywords
  • Rosiglitazone
  • Medicine
  • Impaired fasting glucose
  • Impaired glucose tolerance
  • Internal medicine
  • Thiazolidinedione
  • Placebo
  • Diabetes mellitus
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.